Cause-specific death assessment of patients with stage I small-cell lung cancer: a competing risk analysis

Jiaqing Liu
Jiaqing Liu
Huaqiang Zhou
Huaqiang Zhou
Shen Zhao
Shen Zhao
Xi Chen
Xi Chen
Zhonghan Zhang
Zhonghan Zhang
Wei Xian
Wei Xian
Jiayi Shen
Jiayi Shen

Future oncology (London, England), 2019.

Cited by: 0|Bibtex|Views6|Links
WOS
Keywords:
SCLCSEERcancer-specific deathcompeting risk nomogram

Abstract:

Stage I small-cell lung cancer (SCLC) is a potentially curable disease that needs timely and multidisciplinary management. The aim of this study was to evaluate the probability of cause-specific mortality for patients with stage I SCLC. We identified patients in the SEER database and constructed a proportional subdistribution hazard mod...More

Code:

Data:

Your rating :
0

 

Tags
Comments